Chemocentryx reported $317.13M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amgen AMGN:US $ 19099M 2200M
AstraZeneca AZN:LN 27.27B 8.54B
Bayer BAYN:GR 32.45B 3.35B
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Bristol Myers Squibb BMY:US $ 29161M 2050M
Chemocentryx CCXI:US $ 317.13M 73.51M
GlaxoSmithKline GSK:LN 17.57B 958M
Glaxosmithkline GSK:US $ 17566M 958M
Macrogenics MGNX:US $ 367M 7.72M
Mirati Therapeutics MRTX:US $ 1278.09M 25.42M
Novartis NOVN:VX 23.81B 1.61B
Omeros OMER:US $ 112.4M 20.08M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Takeda 4502:JP Y 2476458M 236435M
Teva Pharmaceutical TEVA:IT 12.82B 421M
YTE INCY:US $ 2620.06M 170.09M